Prosecution Insights
Last updated: October 27, 2026

Cfd Research Corporation

Technology areas: Chemistry & Materials • Medical Devices & Mechanical Engineering

3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days

Analysis

Cfd Research Corporation has 3 pending office actions within the Medical Devices & Mechanical Engineering technology area. These actions are distributed among 3 distinct examiners and 2 distinct art units. HOBBS, MICHAEL L, is the busiest examiner, currently managing 1 busiest examiner pending action. The 3 pending actions are handled by different examiners, but they are focused within only 2 art units.

The distribution of 3 pending office actions across 2 distinct art units suggests that the company's research is technically concentrated. While 3 distinct examiners are involved, the limited number of art units indicates that the subject matter falls into a narrow range of mechanical or medical classifications. HOBBS, MICHAEL L, as the busiest examiner with 1 action, is one of three individuals reviewing the company's current applications. This arrangement means that each of the 3 pending actions is subject to an independent evaluation by a different examiner. Practitioners must manage 3 separate examiner relationships while ensuring that arguments remain consistent across the 2 distinct art units. The presence of 3 pending office actions shows a focused effort to secure patent rights in the Medical Devices & Mechanical Engineering sector. This structure allows for a specialized prosecution approach within a small number of art units. The alignment of the workload ensures that the portfolio benefits from multiple perspectives while remaining focused.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

3
Total Pending OAs
2
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
1
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (33%)
1
Medium (33%)
1
Easy (33%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (33%)
§112 only1 (33%)
Multi-statute (no §101)1 (33%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
33% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
2
Mechanical / Eng
67% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

30 h
Manual time on pending OAs
6 h
Time saved (low, 20%)
10 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HOBBS, MICHAEL L 1 68.7% +28.4%
GRANT, MICHAEL CHRISTOPHER 1 22.0% +7.1%
FRISBY, KESHA 1 52.9% +23.3%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18665244 IN VITRO DEVICE FOR VASCULARIZED MICROFLUIDIC MODELING OF OSTEOCHONDRAL UNIT HOBBS, MICHAEL L —
18541346 VITRO MODEL DEVICE FOR CORNEA BARRIER GRANT, MICHAEL CHRISTOPHER —

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18511347 IN VITRO MODEL DEVICE FOR PLACENTAL BARRIER FRISBY, KESHA 7d
18665244 IN VITRO DEVICE FOR VASCULARIZED MICROFLUIDIC MODELING OF OSTEOCHONDRAL UNIT HOBBS, MICHAEL L —

Top Art Units

Art UnitApps
3715 2
1799 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18665244 IN VITRO DEVICE FOR VASCULARIZED MICROFLUIDIC MODELING OF OSTEOCHONDRAL UNIT HOBBS, MICHAEL L 1799 §102§103§112 Non-Final OA — Pending May 15, 2024
18541346 VITRO MODEL DEVICE FOR CORNEA BARRIER GRANT, MICHAEL CHRISTOPHER 3715 §103 Final Rejection — Pending Dec 15, 2023
18511347 IN VITRO MODEL DEVICE FOR PLACENTAL BARRIER FRISBY, KESHA 3715 §112 Non-Final OA 7d Pending Nov 16, 2023

Managing Cfd Research Corporation's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Cfd Research Corporation have?

Cfd Research Corporation has 3 pending office actions as of October 2026, spread across 2 art units and 3 examiners.

Which USPTO examiner handles the most Cfd Research Corporation applications?

Michael L Hobbs has the most, with 1 of Cfd Research Corporation's pending office actions.

What technology area are Cfd Research Corporation's patent applications in?

Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month